世界のT細胞白血病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global T-cells Leukemia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4938
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、T細胞白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、化学療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・T細胞白血病治療の市場動向
・企業の競争状況、市場シェア
・T細胞白血病治療の種類別市場規模と予測2016-2027（手術、化学療法、放射線療法）
・T細胞白血病治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・T細胞白血病治療の北米市場規模2016-2027（アメリカ、カナダ）
・T細胞白血病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・T細胞白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・T細胞白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・T細胞白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（BioCryst Pharmaceuticals、Celgene、GlaxoSmithKline、Kirin Holdings、Otsuka Holdings、Mundipharma International、Novartis）
・結論

Leukemia refers to cancer of the blood cells. It occurs due to changes in the bone marrow characterized with uncontrollable growth of the blood cells.

Market Analysis and Insights: Global T-cells Leukemia Treatment Market
The global T-cells Leukemia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T-cells Leukemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T-cells Leukemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T-cells Leukemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T-cells Leukemia Treatment market.

Global T-cells Leukemia Treatment Scope and Market Size
T-cells Leukemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-cells Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Chemotherapy
Radiation Therapy

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioCryst Pharmaceuticals
Celgene
GlaxoSmithKline
Kirin Holdings
Otsuka Holdings
Mundipharma International
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-cells Leukemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.3 Market by Application
1.3.1 Global T-cells Leukemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global T-cells Leukemia Treatment Market Perspective (2016-2027)
2.2 T-cells Leukemia Treatment Growth Trends by Regions
2.2.1 T-cells Leukemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T-cells Leukemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 T-cells Leukemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 T-cells Leukemia Treatment Industry Dynamic
2.3.1 T-cells Leukemia Treatment Market Trends
2.3.2 T-cells Leukemia Treatment Market Drivers
2.3.3 T-cells Leukemia Treatment Market Challenges
2.3.4 T-cells Leukemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top T-cells Leukemia Treatment Players by Revenue
3.1.1 Global Top T-cells Leukemia Treatment Players by Revenue (2016-2021)
3.1.2 Global T-cells Leukemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global T-cells Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T-cells Leukemia Treatment Revenue
3.4 Global T-cells Leukemia Treatment Market Concentration Ratio
3.4.1 Global T-cells Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-cells Leukemia Treatment Revenue in 2020
3.5 T-cells Leukemia Treatment Key Players Head office and Area Served
3.6 Key Players T-cells Leukemia Treatment Product Solution and Service
3.7 Date of Enter into T-cells Leukemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 T-cells Leukemia Treatment Breakdown Data by Type
4.1 Global T-cells Leukemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global T-cells Leukemia Treatment Forecasted Market Size by Type (2022-2027)

5 T-cells Leukemia Treatment Breakdown Data by Application
5.1 Global T-cells Leukemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global T-cells Leukemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America T-cells Leukemia Treatment Market Size (2016-2027)
6.2 North America T-cells Leukemia Treatment Market Size by Type
6.2.1 North America T-cells Leukemia Treatment Market Size by Type (2016-2021)
6.2.2 North America T-cells Leukemia Treatment Market Size by Type (2022-2027)
6.2.3 North America T-cells Leukemia Treatment Market Size by Type (2016-2027)
6.3 North America T-cells Leukemia Treatment Market Size by Application
6.3.1 North America T-cells Leukemia Treatment Market Size by Application (2016-2021)
6.3.2 North America T-cells Leukemia Treatment Market Size by Application (2022-2027)
6.3.3 North America T-cells Leukemia Treatment Market Size by Application (2016-2027)
6.4 North America T-cells Leukemia Treatment Market Size by Country
6.4.1 North America T-cells Leukemia Treatment Market Size by Country (2016-2021)
6.4.2 North America T-cells Leukemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe T-cells Leukemia Treatment Market Size (2016-2027)
7.2 Europe T-cells Leukemia Treatment Market Size by Type
7.2.1 Europe T-cells Leukemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe T-cells Leukemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe T-cells Leukemia Treatment Market Size by Type (2016-2027)
7.3 Europe T-cells Leukemia Treatment Market Size by Application
7.3.1 Europe T-cells Leukemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe T-cells Leukemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe T-cells Leukemia Treatment Market Size by Application (2016-2027)
7.4 Europe T-cells Leukemia Treatment Market Size by Country
7.4.1 Europe T-cells Leukemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe T-cells Leukemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific T-cells Leukemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific T-cells Leukemia Treatment Market Size by Type
8.2.1 Asia-Pacific T-cells Leukemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T-cells Leukemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T-cells Leukemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific T-cells Leukemia Treatment Market Size by Application
8.3.1 Asia-Pacific T-cells Leukemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T-cells Leukemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T-cells Leukemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific T-cells Leukemia Treatment Market Size by Region
8.4.1 Asia-Pacific T-cells Leukemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T-cells Leukemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America T-cells Leukemia Treatment Market Size (2016-2027)
9.2 Latin America T-cells Leukemia Treatment Market Size by Type
9.2.1 Latin America T-cells Leukemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America T-cells Leukemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America T-cells Leukemia Treatment Market Size by Type (2016-2027)
9.3 Latin America T-cells Leukemia Treatment Market Size by Application
9.3.1 Latin America T-cells Leukemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America T-cells Leukemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America T-cells Leukemia Treatment Market Size by Application (2016-2027)
9.4 Latin America T-cells Leukemia Treatment Market Size by Country
9.4.1 Latin America T-cells Leukemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America T-cells Leukemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa T-cells Leukemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa T-cells Leukemia Treatment Market Size by Type
10.2.1 Middle East & Africa T-cells Leukemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T-cells Leukemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T-cells Leukemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa T-cells Leukemia Treatment Market Size by Application
10.3.1 Middle East & Africa T-cells Leukemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T-cells Leukemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T-cells Leukemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa T-cells Leukemia Treatment Market Size by Country
10.4.1 Middle East & Africa T-cells Leukemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T-cells Leukemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioCryst Pharmaceuticals
11.1.1 BioCryst Pharmaceuticals Company Details
11.1.2 BioCryst Pharmaceuticals Business Overview
11.1.3 BioCryst Pharmaceuticals T-cells Leukemia Treatment Introduction
11.1.4 BioCryst Pharmaceuticals Revenue in T-cells Leukemia Treatment Business (2016-2021)
11.1.5 BioCryst Pharmaceuticals Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene T-cells Leukemia Treatment Introduction
11.2.4 Celgene Revenue in T-cells Leukemia Treatment Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline T-cells Leukemia Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in T-cells Leukemia Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Kirin Holdings
11.4.1 Kirin Holdings Company Details
11.4.2 Kirin Holdings Business Overview
11.4.3 Kirin Holdings T-cells Leukemia Treatment Introduction
11.4.4 Kirin Holdings Revenue in T-cells Leukemia Treatment Business (2016-2021)
11.4.5 Kirin Holdings Recent Development
11.5 Otsuka Holdings
11.5.1 Otsuka Holdings Company Details
11.5.2 Otsuka Holdings Business Overview
11.5.3 Otsuka Holdings T-cells Leukemia Treatment Introduction
11.5.4 Otsuka Holdings Revenue in T-cells Leukemia Treatment Business (2016-2021)
11.5.5 Otsuka Holdings Recent Development
11.6 Mundipharma International
11.6.1 Mundipharma International Company Details
11.6.2 Mundipharma International Business Overview
11.6.3 Mundipharma International T-cells Leukemia Treatment Introduction
11.6.4 Mundipharma International Revenue in T-cells Leukemia Treatment Business (2016-2021)
11.6.5 Mundipharma International Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis T-cells Leukemia Treatment Introduction
11.7.4 Novartis Revenue in T-cells Leukemia Treatment Business (2016-2021)
11.7.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global T-cells Leukemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation Therapy
Table 5. Global T-cells Leukemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global T-cells Leukemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global T-cells Leukemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global T-cells Leukemia Treatment Market Share by Regions (2016-2021)
Table 9. Global T-cells Leukemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global T-cells Leukemia Treatment Market Share by Regions (2022-2027)
Table 11. T-cells Leukemia Treatment Market Trends
Table 12. T-cells Leukemia Treatment Market Drivers
Table 13. T-cells Leukemia Treatment Market Challenges
Table 14. T-cells Leukemia Treatment Market Restraints
Table 15. Global T-cells Leukemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global T-cells Leukemia Treatment Market Share by Players (2016-2021)
Table 17. Global Top T-cells Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-cells Leukemia Treatment as of 2020)
Table 18. Ranking of Global Top T-cells Leukemia Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by T-cells Leukemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-cells Leukemia Treatment Product Solution and Service
Table 22. Date of Enter into T-cells Leukemia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-cells Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global T-cells Leukemia Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global T-cells Leukemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global T-cells Leukemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global T-cells Leukemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global T-cells Leukemia Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global T-cells Leukemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global T-cells Leukemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America T-cells Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America T-cells Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America T-cells Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America T-cells Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America T-cells Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America T-cells Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe T-cells Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe T-cells Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe T-cells Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe T-cells Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe T-cells Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe T-cells Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific T-cells Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific T-cells Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific T-cells Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific T-cells Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific T-cells Leukemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific T-cells Leukemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America T-cells Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America T-cells Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America T-cells Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America T-cells Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America T-cells Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America T-cells Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa T-cells Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa T-cells Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa T-cells Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa T-cells Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa T-cells Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa T-cells Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. BioCryst Pharmaceuticals Company Details
Table 63. BioCryst Pharmaceuticals Business Overview
Table 64. BioCryst Pharmaceuticals T-cells Leukemia Treatment Product
Table 65. BioCryst Pharmaceuticals Revenue in T-cells Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 66. BioCryst Pharmaceuticals Recent Development
Table 67. Celgene Company Details
Table 68. Celgene Business Overview
Table 69. Celgene T-cells Leukemia Treatment Product
Table 70. Celgene Revenue in T-cells Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 71. Celgene Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline T-cells Leukemia Treatment Product
Table 75. GlaxoSmithKline Revenue in T-cells Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Kirin Holdings Company Details
Table 78. Kirin Holdings Business Overview
Table 79. Kirin Holdings T-cells Leukemia Treatment Product
Table 80. Kirin Holdings Revenue in T-cells Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 81. Kirin Holdings Recent Development
Table 82. Otsuka Holdings Company Details
Table 83. Otsuka Holdings Business Overview
Table 84. Otsuka Holdings T-cells Leukemia Treatment Product
Table 85. Otsuka Holdings Revenue in T-cells Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 86. Otsuka Holdings Recent Development
Table 87. Mundipharma International Company Details
Table 88. Mundipharma International Business Overview
Table 89. Mundipharma International T-cells Leukemia Treatment Product
Table 90. Mundipharma International Revenue in T-cells Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 91. Mundipharma International Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis T-cells Leukemia Treatment Product
Table 95. Novartis Revenue in T-cells Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-cells Leukemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Global T-cells Leukemia Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. T-cells Leukemia Treatment Report Years Considered
Figure 10. Global T-cells Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global T-cells Leukemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global T-cells Leukemia Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global T-cells Leukemia Treatment Market Share by Regions (2022-2027)
Figure 14. Global T-cells Leukemia Treatment Market Share by Players in 2020
Figure 15. Global Top T-cells Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-cells Leukemia Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by T-cells Leukemia Treatment Revenue in 2020
Figure 17. Global T-cells Leukemia Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global T-cells Leukemia Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America T-cells Leukemia Treatment Market Share by Type (2016-2027)
Figure 21. North America T-cells Leukemia Treatment Market Share by Application (2016-2027)
Figure 22. North America T-cells Leukemia Treatment Market Share by Country (2016-2027)
Figure 23. United States T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe T-cells Leukemia Treatment Market Share by Type (2016-2027)
Figure 27. Europe T-cells Leukemia Treatment Market Share by Application (2016-2027)
Figure 28. Europe T-cells Leukemia Treatment Market Share by Country (2016-2027)
Figure 29. Germany T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific T-cells Leukemia Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific T-cells Leukemia Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific T-cells Leukemia Treatment Market Share by Region (2016-2027)
Figure 39. China T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America T-cells Leukemia Treatment Market Share by Type (2016-2027)
Figure 47. Latin America T-cells Leukemia Treatment Market Share by Application (2016-2027)
Figure 48. Latin America T-cells Leukemia Treatment Market Share by Country (2016-2027)
Figure 49. Mexico T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa T-cells Leukemia Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa T-cells Leukemia Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa T-cells Leukemia Treatment Market Share by Country (2016-2027)
Figure 55. Turkey T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE T-cells Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. BioCryst Pharmaceuticals Revenue Growth Rate in T-cells Leukemia Treatment Business (2016-2021)
Figure 59. Celgene Revenue Growth Rate in T-cells Leukemia Treatment Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in T-cells Leukemia Treatment Business (2016-2021)
Figure 61. Kirin Holdings Revenue Growth Rate in T-cells Leukemia Treatment Business (2016-2021)
Figure 62. Otsuka Holdings Revenue Growth Rate in T-cells Leukemia Treatment Business (2016-2021)
Figure 63. Mundipharma International Revenue Growth Rate in T-cells Leukemia Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in T-cells Leukemia Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global T-cell Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、T細胞急性リンパ芽球性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の慢性リンパ性白血病（CLL）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4011 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、慢性リンパ性白血病（CLL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL初期治療、CLL二次治療）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の慢性骨髄性白血病（CML）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4014 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、慢性骨髄性白血病（CML）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、化学療法、放射線療法、脾臓摘出術、幹細胞移植）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米...

世界の成人T細胞白血病/リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3768 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、成人T細胞白血病/リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブレンツキシマブベドチン、HBI-8000、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別...

世界のB細胞慢性リンパ性白血病治療市場規模・現状・予測（2021年-2027年）

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3892 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、B細胞慢性リンパ性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、...

世界の白血病分子診断市場規模・現状・予測（2021年-2027年）

Global Leukemia Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4423 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、白血病分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の合成幹細胞市場規模・現状・予測（2021年-2027年）

Global Synthetic Stem Cells Market Size, Status and Forecast 2021-2027
QFJ1-4925 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、合成幹細胞の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心血管疾患、神経障害、その他疾患）、用途別市場規模（癌、傷・怪我、筋骨格系障害、造血系疾患）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の慢性リンパ性白血病治療薬市場規模・現状・予測（2021年-2027年）

Global Chronic Lymphocytic Leukemia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4012 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、慢性リンパ性白血病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、点滴薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の急性リンパ性/リンパ芽球性白血病（ALL）治療法市場規模・現状・予測（2021年-2027年）

Global Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3758 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、急性リンパ性/リンパ芽球性白血病（ALL）治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Hyper-CVADレジメン、リンカーレジメン、ヌクレオシド系代謝阻害剤（クロル、ネララビン）、標的薬剤...

世界のヒト間葉系幹細胞 (hMSC)市場規模・現状・予測（2021年-2027年）

Global Human Mesenchymal Stem Cells (hMSC) Market Size, Status and Forecast 2021-2027
QFJ1-4331 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ヒト間葉系幹細胞 (hMSC)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（臍帯マトリックス hMSC、骨髄hMSC、脂肪組織hMSC、その他）、用途別市場規模（医療用、研究所、その他）、主要地域別...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年） T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood cells called T lymphocytes. Market Analysis and Insights: Global T-cell Acute Lymphoblastic Leukemia Treatment Market The global T-cell Acute Lymphoblastic…
世界の慢性骨髄性白血病（CML）治療市場規模・現状・予測（2021年-2027年） Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow. Market Analysis and Insights: Global Chronic Myeloid Leukemia (CML) Treatment Market The global Chronic Myeloid Leukemia (CML) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX mil…
世界の慢性リンパ性白血病（CLL）治療市場規模・現状・予測（2021年-2027年） Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for treating (for example, which symptoms it is causing). Market Analysis and Insights: Global Chronic Lymphocytic Leukemia (CLL) Treatment Market The global C…
世界の成人T細胞白血病/リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Adult T-Cell Leukemia/Lymphoma Treatment Market The global Adult T-Cell Leukemia/Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界のB細胞慢性リンパ性白血病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…